Rakesh K. Pathak, Ph.D
Affiliations: | 2017- | Chemistry | IISER Berhampur |
Area:
Nanomedicine, Bio-inorganic chemistry, Drug delivery, Cisplatin based prodrugsWebsite:
https://www.rakeshpathaklab.com/Google:
"http://scholar.google.com/citations?user=O0Fb5ykAAAAJ&hl=en"Mean distance: 39813
Parents
Sign in to add mentor| Chebrolu Pulla Rao | grad student | 2006-2011 | IIT Bombay | |
| (Calix[4]arene Conjugates: Synthesis, Characterization, Ion Binding And Biointeraction Studies) | ||||
| Shanta Dhar | post-doc | 2012-2015 | University of Georgia | |
| Rajgopal Govindarajan | post-doc | 2015-2017 | Ohio State (Cell Biology Tree) | |
Children
Sign in to add trainee| Arka Banerjee | grad student | 2019- | IISER Berhampur |
| Megha Biswas | grad student | 2019- | IISER Berhampur |
| Anup Kumar Pramanik | post-doc | 2017- | IISER Berhampur |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Banerjee A, Bajaj G, Singhal NK, et al. (2023) Synthetically Tunable Suprahybrid Nanoparticle Platform for the Efficacious Delivery of Therapeutics. Acs Applied Materials & Interfaces |
| Nair S, Strohecker AM, Persaud AK, et al. (2019) Adult stem cell deficits drive Slc29a3 disorders in mice. Nature Communications. 10: 2943 |
| Pathak RK, Basu U, Ahmad A, et al. (2018) A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation. Biomaterials. 187: 117-129 |
| Mody HR, Hung SW, Naidu K, et al. (2017) SET contributes to the epithelial-mesenchymal transition of pancreatic cancer. Oncotarget. 8: 67966-67979 |
| Mody H, Hung SW, Pathak R, et al. (2017) miR-202 Diminishes TGFbeta Receptors and Attenuates TGFbeta1-induced EMT in Pancreatic Cancer. Molecular Cancer Research : McR |
| Pathak RK, Wen R, Kolishetti N, et al. (2017) A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer. Molecular Cancer Therapeutics |
| Basu U, Banik B, Wen R, et al. (2016) The Platin-X series: activation, targeting, and delivery. Dalton Transactions (Cambridge, England : 2003) |
| Pathak RK, Dhar S. (2016) Unique Use of Alkylation for Chemo-Redox Activity by a Pt(IV) Prodrug. Chemistry (Weinheim An Der Bergstrasse, Germany). 22: 3029-36 |
| Wen R, Banik B, Pathak RK, et al. (2016) Nanotechnology inspired tools for mitochondrial dysfunction related diseases. Advanced Drug Delivery Reviews |
| Mummidivarapu VVS, Pathak RK, Rao CP. (2016) Structure of a di-zinc complex of a bis-calix[4]arene conjugate and its sensing of cysteine among the amino acids Supramolecular Chemistry. 1-8 |